|
Name: Clonazepam
Type: Benzodiazepine
AKA: Klonopin, Clonopin
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Clonazepam, a benzodiazepine, was first synthesized in the 1960s. It is used primarily for its anxiolytic, anticonvulsant, and muscle relaxant properties. Its history includes its widespread use in treating seizures and anxiety, along with issues of dependence and regulation.
|
|
V. Legal Information
Clonazepam, a benzodiazepine used for anxiety and seizure disorders, is classified as a Schedule IV controlled substance in the US. Globally, its status reflects similar controls to manage its use while preventing misuse and addiction.
US Federal Schedule - IV
Schedule IV drugs, substances, or chemicals are defined as drugs with a low potential for abuse and low risk of dependence. Some examples of Schedule IV drugs are: Xanax, Soma, Darvon, Darvocet, Valium, Ativan, Talwin, Ambien, Tramadol.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Clonazepam, a benzodiazepine, is used to treat anxiety and seizures. As a downer, it induces significant sedation and relaxation. Short-term effects include reduced anxiety and seizure control, while long-term use can lead to dependence and cognitive impairment. Overdose risks involve severe sedation and respiratory issues. Safe dosing typically ranges from 0.5-2 mg daily. Recent research focuses on its efficacy and potential for misuse.  |
|
VII. Psychological Effects
Clonazepam, a benzodiazepine, enhances GABA-A receptor activity, providing anxiolytic and anticonvulsant effects. Immediate effects include reduced anxiety and improved mood, with long-term use potentially leading to cognitive decline and dependence. Research focuses on its efficacy for anxiety disorders and potential cognitive side effects.
 |
|
VIII. Culture
Clonazepam is a benzodiazepine used for anxiety and seizure disorders, classifying it as a downer. Short-term use induces sedation and anxiety relief, while long-term use can lead to dependence, tolerance, and cognitive impairment. Overdose risks include severe sedation, respiratory depression, and potential coma. Safe dosages are prescribed by medical professionals. Recent research highlights its effectiveness in treating anxiety and seizures but warns of high dependence risks and cognitive effects. Physical effects include drowsiness, impaired coordination, and potential respiratory depression.
 |